|
|
|
|
 | | FAQ #7 - What Happens If My IVF Cycle Fails? | 4/25/2013 8:35 PM |
No one likes to consider the possibility of an IVF cycle not resulting in pregnancy. The reality is, however, that at least 30-40% of the time, it will not. After the emotional dust settles, it is very important that we sit down and critically review the treatment cycle to try to learn more from the experience. We call this a “failed cycle meeting”. A failed cycle meeting is just as important as the actual treatment cycle. In the meeting, all aspects of the treatment cycle will be reviewed.
The review should evaluate both embryonic reasons for IVF failure and environmental reasons:
Embryonic reasons will evaluate any potential problems with the eggs, sperm and/or embryos that might have resulted in the lack of pregnancy or miscarriage. Things such as the protocol (medications and dosages used), number of follicles, estrogen levels, size of follicles at the time that hCG was given, number of eggs obtained, egg maturity, fertilization rate, percentage of embryos that progress to blastocyst (implantation stage, typically day 5 or 6 of embryonic life) and quality of the blastocysts (this can include genetic testing of embryos- called complete chromosomal screening (CCS)). Problems in this area might be due to egg quality or the type of stimulation utilized.. Sometimes, adjustments can be made to the stimulation protocol that might ultimately improve embryo quality and pregnancy outcome.
Environmental factors are also an important aspect of the failed IVF cycle meeting. This area will include things such as the preparedness of the uterus (endometrial thickness and structure), immune factors (including both autoimmune and alloimmune problems) as well as the embryo transfer. Immunologic factors can be tested using parental blood and might include tests such as antiphospholipid antibodies.
These areas will be discussed openly and honestly so that any future IVF attempts can be revised to improve the chances of a positive outcome. The point here is to have an opportunity to put our heads together, and allow you to ask questions in order to improve the chances for pregnancy on your next IVF attempt. | | Contact:
Contact Conceptions Fertility Clinic at 303-794-0045 or view our contact us page |  |  |  | | National Infertility Awareness Week (NIAW) - April 21-27, 2013 | 4/15/2013 8:24 PM |
Infertility is a disease affecting one out of every six couples in the United States, 7.3 million nationally. Are you suffering or know someone who is suffering with infertility? Infertility isn't whispered about between girlfriends anymore, infertility is A REAL disease and needs to be talked about. Women are not the only ones affected by infertility 30-40% of males are affected by the disease as well.
-
If you are 35 or older, have you been trying to conceive for more than 6 months without success?
-
If you are under 35, have you been trying to conceive for a year or more without success?
-
Have you had two or more miscarriages or pregnancy loss?
-
Has your spouse or partner been tested for fertility problems?
-
Do you suffer from painful periods or irregular periods?
If you answered Yes to 1 of the above questions talk with your Women’s Health Care provider to discuss your treatment options.
Help is available; speak with someone who cares.
For additional infertility information visit American Fertility Association.
For information on NIAW visit RESOLVE. | | Contact:
Contact Conceptions Fertility Clinic at 303-794-0045 or view our contact us page |  |  |  | | Introducing the NEW Heart to Heart patient video essay contest! | 3/26/2013 2:11 PM |
|
This contest is open to infertility patients who achieved their dream of parenthood with a little help from BRAVELLE® (urofollitropin for injection, purified), MENOPUR® (menotropins for injection, USP), and/or other qualifying Ferring fertility products, in an assisted reproductive technology (ART) cycle. To enter, the patient must submit a video entry that creatively tells the patient’s story of success with qualifying Ferring fertility products. Prizes • Grand prize: $15,000 educational fund (as a 529 or similar savings plan) • Four runners-up: $2000 educational fund (as a 529 or similar savings plan) |
| | | Contact:
Enter the Contest at www.hearttoheartcontest.com |  |  |  | | FAQ #6 - FERTILITY PRESERVATION FOR THE CANCER PATIENT | 2/28/2013 8:57 PM | It is estimated that 140,000 people under the age of 50 are diagnosed with a malignancy each year in the United States. The good news is that cancer survival rates are higher than they have ever been, likely as a result of early detection programs and advancements in treatment protocols. Patients with cancer are now able to live substantially longer and lead more productive lives. Therefore, quality of life issues, such as maintaining fertility potential, have become important areas of research. It is well known that surgery, chemotherapy, and/or radiotherapy administered during the adolescent or reproductive years can leave cancer survivors unable to fulfill their desire for having a family.
The American Society of Clinical Oncology released specific recommendations on fertility preservation in cancer patients to improve the information flow to the reproductive community. It states, “As part of informed consent prior to therapy, oncologists should address the possibility of infertility with patients as early in treatment planning as possible. As part of education and informed consent before cancer therapy, oncologists should address the possibility of infertility with patients treated during their reproductive years and be prepared to discuss possible fertility preservation options or refer appropriate and interested patients to reproductive specialists”. The problem lies in that a majority of oncologists do not discuss this issue at diagnosis routinely or patients feel the information they received was inadequate. Therefore, many patients do not realize until it’s too late that their fertility potential is diminished or completely absent.
The challenge, as reproductive specialists, is meeting the unique needs of cancer patients and survivors.
Role of the Reproductive Specialist As a fertility specialist, I will primarily see two types of cancer patients: newly diagnosed patients and long-term survivors. Newly diagnosed patients will be seeking assistance with fertility preservation methods before the initiation of cancer treatment. Cancer survivors may require assistance in order to have a child after treatment or remission of their cancer. The needs of these patients are distinct from those of your standard infertility patients; therefore, require modifications to my standard practices.
Newly diagnosed cancer patients are dealing with a shock and emotional distress inherent to their cancer diagnosis. Then, as reproductive specialists, we give a second traumatic shock for these patients to consider: their possible infertility. These patients will likely need increased emotional support and sensitivity from those around them.
These patients will also have a short period of time in which he or she will be able to undergo fertility preservation techniques: time is of the essence. Discussion at the earliest possible opportunity is encouraged to allow patients fullest range of options. For example, several patients will have approximately two to six weeks between surgery and adjuvant therapy, which may be an opportune time for fertility preservation. Others may have less time; therefore, not meeting eligibility requirements for standard fertility procedures. Patients, especially female patients, must be counseled in an expedited fashion in order to afford them their full range of fertility preservation options.
It is important for patients to understand treatment effects and the possible impact on future fertility options. Communication is a key component in the care of these individuals.
Visit our Fertility Preservation for Cancer page for resources and information on making an appointment to discuss your individual fertility needs. | | Contact:
Contact Conceptions Fertility Clinic at 303-794-0045 or view our contact us page |  |  |  | | FAQ #5 - Egg Health Testing and Diminished Ovarian Reserve (DOR) | 2/1/2013 4:06 PM | At birth, women have 1-2 million eggs. This number slowly decreases throughout life. At puberty, a woman has approximately 250,000 eggs, in her 20's this number decreases to 100,000, in her 30's it's down to 10,000, in her 40s as low as 1,000, and by the time she reaches menopause she will have no functional eggs left. As these numbers decline, so does the quality of those eggs. As a result, the ability to become pregnant decreases and the rate of miscarriage increases as a female ages. For example, a classic French study done with women using donor sperm showed a 74% pregnancy rate with up to 12 inseminations for women younger than 31 years old versus 54% for women over 35. Similar trends are seen with embryo transfers resulting in live births, 44.9% for women under 35 and 26.6% for women 38-40 years old. The rate of miscarriage also increases as women age from 11.4% in women 33-34 years old compared to <45% for women 41-42 years old. For this reason, it is very important to evaluate egg health in trying to become pregnant, especially if you are over 33 years old, have unexplained infertility, have menopausal symptoms (such as shortened menstrual cycles or hot flashes), or have had previous ovarian surgery.
In the early follicular phase of a woman's menstrual cycle, specific hormones can be measured in the blood to provide an approximation of how many eggs the ovaries have and if they are still healthy. Follicle Stimulating Hormone (FSH) and Estradiol levels are measured by a simple blood draw. Elevated levels of FSH and Estradiol, during this time, can indicate a decreased ability to achieve live birth compared to someone with normal levels at the same age.
There is one other blood test that can be drawn at any time during a women's cycle that corresponds to egg health. This blood test is an anti-mullerian hormone (AMH) level. AMH is released by the granulosa cells of the follicles, so it corresponds to the antral follicle count. In general an AMH level >2 is normal with healthy ovarian reserve and <1 suggests poor egg health or diminished ovarian reserve.
A transvaginal ultrasound can also be done in the early follicular phase to count the number of small follicles (2-10mm in size) on each ovary. The number of these follicles reflect underlying egg supply and the ability of those eggs to be recruited for ovulation. Lower resting or antral follicle counts correspond with decreased egg health and diminished ovarian reserve.
The evaluation of egg health and identification of diminished ovarian reserve can provide good insight as to a woman's chances of becoming pregnant and the likelihood of having a miscarriage, assuming other factors that effect fertility have been evaluated and are within normal limits. It can also guide providers to select appropriate fertility treatments and plan what is best for that patient. For patients with DOR, unfortunately it is not reversible. However, there are some treatment options. 1) DHEA, a medication that helps make eggs more responsive to recruitment 2) In vitro fertilization with genetic testing of embryos prior to transfer 3) Donor egg in vitro fertilization (IVF)
For this reason, egg health testing is a crucial part of the infertility work up and plan.
References - ASRM and ACOG. Age-Related Fertility Decline. Fertil and Steril 2008 - ASRM, Egg Health Testing asrm.org/detail.aspx?id=1905 - ASRM Practice Comittee. Aging and Infertility in Women. Fertil and Steril 2006 - ASRM, Prediction of Fertility Potential (Ovarian Reserve) in Women asrm.org/Prediction_of_Fertility_Potential_Ovarian_Reserve_in_Women/ - Strauss III and Barbieri, Yen and Jaffe's Reproductive Endocrinology, 5th ed. 2004 | | Contact:
Contact Conceptions Fertility Clinic at 303-794-0045 or view our contact us page |  |  |  | | FAQ#4 - Nutrition and Infertility | 10/30/2012 3:30 PM | One's overall health and well being certainly plays an important role in infertility and trying to conceive. Doing things to improve one's health, such as exercising, changing your diet and taking supplements can help to increase your ability to become pregnant.
Females:
Decreasing inflammation in the gut and throughout the body, provides a more ideal place for conception to occur. This can be done by eating a diet that is limited in processed foods and junk food, and by eating more olive oil, nuts, seeds, oily fish, pasture-fed meat, and live yogurt (or probiotic supplements). All of which have been shown to decrease inflammation throughout the body.
Nutritional supplements, specifically one's that contain chasteberry, L-arginine, vitamins (including folate) and minerals, have been shown to improve pregnancy rates and could be used in conjunction with conventional infertility therapies.
Avoiding caffeine, alcohol and tobacco not only improves fertility, but prepares women for pregnancy when those things should be stopped completely.
Being overweight can also contribute to infertility. Improving your diet and exercising to decrease your body weight by as little as 5% can improve infertility significantly.
Males:
Studies have shown that a diet consisting of fish, chicken, fruits, vegetables, and whole grains improved motility up to 11% compared to those who eat red or processed meat, refined grains, snacks and sweets. However, red meat is also rich in carnitine, vitamins, iron, protein, and natural animals fats, all of which are are important to overall health, so cutting it out of the diet completely may not be necessary.
There is also evidence that a diet high in trans fats, such as margarine, hydrogenated vegetable oils, and to a smaller extent in meat and dairy products, leads to an increased level of trans fatty acids in sperm, which is related to lower sperm concentration.
Drinking alcohol and smoking marijuana or tobacco can also decrease sperm count and motility, so this should be eliminated while trying to conceive.
Certain dietary supplements, such as L carnitine, Acetyl L carnitine, CoEnzyme Q10, Vitamin E and Selenium have also been shown to improve sperm count, morphology (shape) and motility. More importantly, a 2004 study showed increased pregnancy rates with infertile men that used these vitamin supplements (21.8%) versus placebo (1.7%). These are even available in a single supplement, called Proxeed.
References:
-
Agarwal A, Nallella KP, Allamaneni SS, Said TM. Role of antioxidants in treatment of male infertility: an overview of the literature. Reprod Biomed Online. 2004 Jun;8(6):616-627. Review. www.rbmonline.com/Article/1284 on web 7 April 2004.
-
Balercia G, et al.. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril. 2005 Sep;84(3):662-71
-
Beauchamp G, et al. Ibuprofen-like activity in extra-virgin olive oil. Nature 2005;437.
-
Cavallini G, Ferraretti AP, Gianaroli L et al. Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. J Androl. 2004 Sep-Oct;25(5):761-770.
-
Chavarro, et al. Trans fatty acid levels in sperm are associated with sperm concentration among men from an infertility clinic. Fertil Steril. 2011 Apr;95(5):1794-7. Epub 2010 Nov 11
-
Collier-Hymans LS and Neish AS. Innate immune relationship between commensal flora and the mammalian intestinal epithelium. Cell Mol Life Sci 2005; 62-1339-48.
-
Crawford MA, et al. Comparative studies in fatty acid composition of wild and domestic meats. Int J Biochem 1970;1(3):295-300.
-
Gaskin, et al. Dietary patterns and semen quality in young men. Hum Reprod. 2012 Oct;27(10):2899-907. Epub 2012 Aug 11
-
Menchini-Fabris GF et al. Free L-carnitine in human semen: its variability in different andrologic pathologies. Fertil Steril. 1984 Aug;42(2):263-7.
-
Sheil B, et al. Probiotic effects on inflammatory bowel disease. J Nutri 2007;137:819-24S
-
Wall R, et al. Fatty acids from fish, the anti-inflammatory potential of long-chain-fatty-acids. Nutri Rev 2010;68:280-9.
-
Westfall LM, et al. Double-blind, placebo-controlled study of Fertilityblend: a nutritional supplement for improving fertility in women. Clin Exp Obstet Gynecol. 2006;33(4):205-8. | | Contact:
Contact Conceptions at 303-794-0045 or view our contact us page |  |  |  | | FAQ #3 - What is Polycystic Ovarian Syndrome (PCOS)? | 9/23/2012 8:32 PM |
What is PCOS?
PCOS is a very common endocrine disorder where there is an imbalance in the female sex hormones. These imbalances lead to problems with ovulation, excess androgens or masculinizing hormones and insulin resistance. As a result, someone with PCOS might struggle with irregular periods, difficulty becoming pregnant, acne, abnormal hair growth, obesity, elevated cholesterol, and type 2 diabetes. However, not every women with PCOS will exhibit all of these symptoms. Irregular periods or difficulty getting pregnant could be the only signs. PCOS also appears to be a genetic disease, as there is increased incidence in women with a mother or sister who have PCOS.
How is PCOS diagnosed?
According to the Rotterdam criteria, the diagnosis of PCOS is made if you exhibit at least 2 of the following criteria.
1) Irregular periods (>38 day cycle length) or lack of periods
2) Polycystic ovaries on ultrasound (enlarged ovaries with multiple small cysts, often times they are distributed along the edge of the ovary in a row giving a "string of Pearls" appearance)
3) Hyperandrogenemia (elevated levels of free or total testosterone) OR signs of hyperandrogenism, such as acne and hirsutism (dark coarse hairs in male pattern areas, such as chin, chest or abdomen).
We also need to rule out other etiologies for these signs and symptoms, such as high prolactin levels, abnormal thyroid function, androgen secreting tumors, and congenital adrenal hyperplasia, another endocrine disorder.
Additionally, once you have been diagnosed with PCOS, you are at increased risk for elevated cholesterol, diabetes, heart disease, sleep apnea, and endometrial cancer and need to be monitored more closely for these things.
How does PCOS relate to infertility?
Ovulation, which requires precise elevations of LH and FSH from the hypothalamus at precise times, gets disrupted in PCOS because there is an imbalance of these female sex hormones. Women with PCOS ovulate infrequently and sometimes not at all. As you remember from our initial blog about conception and infertility, one of the requirements for conception to occur is that ovulation must be occurring (releasing of an egg each month). Thus, women with PCOS may have a difficult time getting pregnant.
What is the treatment for PCOS?
There isn't one treatment for PCOS; instead there are multiple treatments that help with the effects of PCOS.
1) Birth Control Pills:
If you aren't trying to become pregnant, birth control pills can be used to treat irregular periods, making them regular. They also help improve acne and slow hair growth.
2) Exercise and Weight loss:
A decrease in body weight by even as little as 5%, can help decrease the effects of PCOS, including anovulation, insulin resistance, and hyperandrogenism.
3) Metformin: This medication decreases both liver glucose production and intestinal glucose absorption. It is also an insulin sensitizer that makes glucose more sensitive to breakdown by insulin. Metformin may help slow the progression of pre-diabetes to overt diabetes. It also decreases LH and free testosterone levels, and increases SHBG. All of these things help restore the normal balance of female sex hormones, improving menstrual function, with more regular periods and ovulation. Metformin is not typically used alone as a first-line fertility medication as it was not shown to improve live birth rates compared to the medication Clomid (Legro, 2007).
4) Spironolactone:
This is an antiandrogen that can be helpful in preventing the excessive hair growth. This medication can be harmful to a growing fetus, so it is imperative that a woman on this medication isn't pregnant.
5) Clomid or other medications that induce ovulation:
This can be used alone or in conjunction with Metformin to help induce ovulation in women with PCOS who are trying to become pregnant. (see our last blog for more information about Clomid).
6) Other treatments, such as laser hair removal, acne medications, and medications to treat high cholesterol levels or diabetes may be indicated.
Legro, et al. New England Journal of Medicine, 2007. | | Contact:
Contact Conceptions at 303-794-0045 or view our contact us page |  |  |  | | FAQ #2 - What about Clomid? | 8/20/2012 9:19 AM | Clomiphene Citrate (Clomid)
Many women undergoing fertility treatment inquire about clomiphene (commonly referred to by the trade name, Clomid). Clomiphene has been around for many years and depending on a woman’s age and fertility testing, is often viewed as first-line treatment for infertility. This drug is considered an “agonist-antagonist”, meaning it acts like estrogen in some parts of the body and acts like an estrogen blocker in other parts of the body. It is able to stimulate ovulation (release of an egg) by actions through the brain (hypothalamus) so that the women’s own hormones secreted by the hypothalamus and pituitary are increased, thereby increasing the drive to the ovaries each month to produce an egg (or a few eggs).
In general, clomiphene is pretty well tolerated by most women. The common side effects of clomiphene include hot flashes, mood swings, and occasional headaches. Other side effects have been reported and there is an increased risk of multiple pregnancy (typically around 8-10%) and a small risk of blood clots and visual changes, although these are (thankfully) very uncommon.
There are several studies evaluating the efficacy and success rates of clomiphene. There is good evidence to show clomiphene will increase the odds of ovulation and pregnancy in certain groups of women. It is often prescribed for women who do not ovulate regularly (a recent report showed ovulation rates up to 73%, Homburg, et al). It is important to remember ovulation rates are not always good surrogates for pregnancy rates. Another classic paper by Guzick, et al, evaluated the success rates of clomiphene with intrauterine insemination in women with unexplained infertility, and found the pregnancy rates were around 8% per cycle. Keep in mind it is important to consider all factors when reviewing the literature: patient age, diagnosis, study design, etc.
The largest study to date was recently published by a large IVF clinic in Boston (Dovey, et al). They evaluated over 4100 cycles of clomiphene with intrauterine insemination (IUI) in over 1700 infertility patients from 2002-2007. This included women with multiple infertility diagnoses. The pregnancy rates per cycle initiated based on age were very interesting:
|
|
< 35 years |
35-37 years |
38-40 years |
41-42 years |
> 42 years |
|
Number of cycles |
2351 |
947 |
614 |
166 |
120 |
|
Pregnancy rate per cycle |
10.1% |
8.2% |
6.5% |
3.6% |
0.8% |
As you can see, although reasonable, the overall success rates with clomiphene are lower than one might expect and decrease significantly with advancing age. Another interesting finding with this study showed that for women that conceived with clomiphene and IUI, the majority (80-90%) did so within the first 3 cycles. Therefore, for most patients, there is little benefit of extending this type of treatment beyond three cycles.
I will sign off by reviewing a concept we covered in our last blog and is displayed in the findings of these studies: maternal age is the most predictive factor in obtaining pregnancy. As clomiphene is not terribly effective for older women, they may be better served by going directly to more aggressive treatment including assisted reproductive technologies.
Homburg, et al. Hum Reprod 2005;20:2043-51 Guzick, et al. Fertil Steril 1998;70:207-13 Dovey, et al. Fertil Steril 2008; 90:2281-2286 | | Contact:
Contact Conceptions at 303-794-0045 or view our contact us page |  |  |  | | FAQ #1 - How to make a baby | 7/9/2012 1:44 PM |
Welcome to the first frequently asked questions (FAQ) blog installment for Conceptions Reproductive Associates! We are happy you have chosen to follow along and we hope you find the various topics and entries informative and helpful. We plan to touch on several topics that seem to come up frequently during consults and Q&A sessions. We welcome your ideas as well, so please send in suggestions if you have a particular area you are interested in.
For the initial blog, I thought it would be prudent to write about the basics: how to make a baby. Clearly most people have the fundamental idea of how this works, but what happens when conception doesn’t happen spontaneously? How long is too long? When should you be evaluated? What is involved in the evaluation? I could go on and on but let’s cover these topics for now and this will likely serve as an excellent springboard for topics and questions in the future.
“Infertility” is defined as the inability to conceive after one year of unprotected intercourse (not using contraception) for women less than 35 years old. For women 35 or older, it is diagnosed after 6 months of unprotected intercourse. Technically speaking, most people are not “infertile”. Most people who are diagnosed as such are truly “subfertile”, meaning it is taking them longer to conceive than average couples their age. On average, 57% of couples will conceive within 3 months, 72% in 6 months, 85% in 1 year, and 93% in 2 years. Age does matter when looking at statistics, and interestingly, maternal age tends to be the primary factor when it comes to predicting fertility. Infertility is considered a public health problem in that it affects over 6 million women in the United States. There has been a recent interest in research to prevent infertility (although not all causes can be prevented).
There are essentially four areas that need to be in working order for conception to happen:
1) Ovulation must be occurring (releasing of an egg each month)
2) The fallopian tubes must be open (this is where fertilization occurs)
3) Sperm must be present and functional
4) The uterine environment must be receptive to pregnancy/implantation
There are far more details about all of these components (I.e. ovarian aging plays a big role), but knowing a few basic concepts will help you get on the right track. It is important to track your menstrual cycles each month. Most women who ovulate regularly will have fairly regular menstrual cycles (often 26-35 days but usually they only vary within a few days of your own “set point”). Basal body temperature charting can be done to track ovulation, and over the counter ovulation predictor kits work very well for most women. In the world of fertility, we often speak of “cycle days”. Cycle day 1 typically refers to the first day of your period (full flow), and often ovulation will occur around cycle day 14-16 for women who have 28-30 day cycles. If you are not having regular cycles as described above, you should seek evaluation sooner to look for potential causes that may be easy to correct. We will often evaluate specific fertility hormones (ovarian reserve testing- a great topic for the next blog), and other hormones that can affect ovulation. Things like polycystic ovarian syndrome (PCOS) are common causes for irregular ovulation.
The fallopian tubes are usually evaluated with some imaging study. The hysterosalpingogram (HSG) is commonly used and this is performed in a radiology department. It involves placing a small catheter into the cervix and injecting dye into the uterus and fallopian tubes to confirm they are patent (open). This exam also evaluates the internal portion of the uterus (uterine cavity) which is not well seen on routine ultrasounds (sonograms). The exam does cause mild discomfort so I would typically recommend taking ibuprofen or acetaminophen prior to the procedure.
A semen analysis is a standard part of the basic fertility evaluation. Even if a man has no risk factors (i.e. tobacco, alcohol, drugs, family history, certain medications, prior surgeries, etc.), we often still see mild abnormalities in the semen analysis. Sometimes we can help improve this with basic lifestyle changes and vitamins. Sometimes we need to involve a specialist in male reproduction depending on the results and clinical history.
Speaking of sperm, the timing of intercourse and “sperm exposure” is quite important. Sperm can actually stay alive in the female cervix for several days; however the period that an egg can be fertilized is quite short (12-24 hours). In general, it is best to time intercourse 2 days before, the day before, and the day of ovulation. The use of ovulation kits can be very helpful in coordinating this.
Finally, the uterus and ovaries can be visualized quite well with a transvaginal ultrasound. This is often done in the early part of the menstrual cycle. This study gives us good information about the structure of the uterus, presence of fibroids (common tumors of the muscle wall), and ovarian structure.
A few last thoughts…remember the primary predictive factor in making a baby is maternal age. Fertility in women actually peaks around age 22-25, and slowly declines after that. Once a woman approaches her mid-30’s, it can become far more difficult to conceive. The number of eggs declines quickly and the quality also diminishes. These changes are often referred to “diminished ovarian reserve”. When you look at graphs of fertility decline in relationship to age, most of those studies were evaluating population data. Each individual may vary, and chronological age may not correspond to ovarian age. What does this mean? Sometimes the ovaries age more quickly than our chronological age. Unfortunately, the opposite doesn’t seem to exist (our ovaries never act “younger” than our chronologic age).
When should someone be evaluated earlier than usual? I would recommend this for older women, those with risk factors such as irregular periods, prior difficulty conceiving, a family history of early menopause, previous gynecologic surgery, or men who have risk factors that may affect sperm function. Remember, when it comes to making a baby, it is always better to be evaluated too soon rather than too late. | | Contact:
Contact Conceptions at 303-794-0045 or view our contact us page |  |  |  | | Connect with Facebook & Twitter | 5/19/2012 3:56 PM |
Conceptions utilizes social media to connect with patients and provide information on Conceptions, Fertility, and IVF. Visit one of our social media pages:
| | Contact:
Contact Conceptions at 303-794-0045 or view our contact us page |  |  |  | | Accreditation by the College of American Pathologists (CAP) | 5/14/2012 9:45 PM | Conceptions Embryology Laboratory has been awarded accreditation by the College of American Pathologists (CAP) based on the results of an onsite inspection.

| | Contact:
Contact Conceptions at 303-794-0045 or view our contact us page |  |  |  | | Ferring Fertility - My Little Miracle Essay Contest | 6/7/2011 10:54 AM |
Win a $10,000, $7,500 or $5,000 Education Fund For Your Miracle Child! Share your story by entering Ferring's eighth annual "My Little Miracle" essay contest.
| | Contact:
Contact Conceptions at 303-794-0045 or view our contact us page |  |  |  | | The American Fertility Association’s - Illuminations Denver | 12/8/2010 10:02 PM |
About Illuminations: Illuminations is the name of the event series that takes place across the country in cities such as Los Angeles, San Francisco, Atlanta, New York and now coming to Denver, celebrating the work of individuals and organizations in local communities who have made a positive difference in the fields of fertility, reproductive health and family building. About the Attendees: In attendance at Illuminations are physicians and other healthcare professionals including nurses, therapists, complementary medical practitioners, patients, and former patients. About the Celebrities: Billy Baldwin, Felicity Huffman, Angela Basset, Jennifer Beals, Marcia Cross, David Marshall Grant, Luke MacFarlane, Olympian Mitch Gaylord, and our own Brenda Strong are just a few of the celebrities that have attended our events. About Your Donations: Illuminations events benefit the work of The American Fertility Association (The AFA), and have raised nearly $1 million to date. Each event highlights one strategic goal of The AFA, and the money raised at the event goes towards supporting the work required to accomplish that strategic goal. Past events have supported infertility prevention, outreach to the lesbian and gay communities and our work with couples having difficulty conceiving. Illuminations Denver will focus on The AFA’s work empowering women to take control of their fertility.
| | Contact:
Conceptions at 303-794-0045 or view our contact us page |  |  |  | | Dr. Mark Bush at Midwest Reproductive Symposium | 6/7/2010 10:53 PM |
Dr. Bush was asked to give two workshops and a lecture at the prestigious Midwest Reproductive Symposium in Chicago in June of 2010. His invited topic was IVF Protocol Management and Implantation. This conference was attended by reproductive physicians, nurses and embryologists from around the world. Dr. Bush's workshops were standing room only. He discussed topics that included management of PCOS, hypothalamic dysfunction, IVF in women who have poor egg health testing who want to use their own eggs, laparoscopic myomectomy and other surgical techniques, as well as innovative testing and management of recurrent pregnancy loss and implantation failure. A copy of his lecture can be found in the lecture library (link). | | Contact:
Contact Conceptions at 303-794-0045 or view our contact us page |  |  |  | | National Infertility Awareness Week April 24 - May 1 2010 | 4/19/2010 6:24 PM |

Infertility is a disease affecting one out of every six couples in the United States 7.3 million nationally.
Are you suffering or know someone who is suffering with
infertility? Infertility isn’t whispered about between girlfriends anymore, infertility is A REAL disease and needs to be talked about.
Women are not the only ones affected by infertility 30-40% of males are affected by the disease as well.
• Are you 35 or older?
• Have you been trying to conceive for more than 6 months?
If you are under age 35, have you been trying to conceive for a year or more without success?
• Have you had two or more miscarriages or pregnancy loss?
• Has your spouse or partner been tested for fertility problems?
• Do you suffer from painful periods or irregular periods?
If you answered Yes to 1 of the above questions talk with your Women’s Health Care provider to discuss your treatment options.
Help is available; speak with someone who cares. | | Contact:
Contact Conceptions at 303-794-0045 or view our contact us page |  |  |  | | New Ways to Connect with Conceptions! | 9/19/2009 11:28 PM |
Conceptions Reproductive Associates of Colorado is pleased to announce the release of a number of new resources to benefit our patients. First of all you may have noticed we have a redesigned website that will enable us to provide you with more Fertility and IVF information than ever before. Additionally, we've added this blog to our site and plan on making posts in the future on various Women's Health topics including Fertility, Pregnancy, IVF, Egg Donation, Obstetrics, Gynecology, and Reproductive Endocrinology. Finally, we're continuing to provide the highest levels of patient care and compassion and would be happy to discuss your needs in person. Please contact us by phone or email through our contact page.
We look forward to working with you to Unlock the Miracle of Life!
Sincerely,
The Conceptions Doctors (Mark Bush, MD; Michael Swanson, MD)
| | Contact:
Contact Conceptions at 303-794-0045 or view our contact us page |  |  |
|
|
|
|

“At Conceptions, the quality of care that our Fertility Patients receive is our
#1 priority!” Dr. Dana Ambler |
|
|